Keryx Biopharmaceuticals, Inc.

(NASDAQ:KERX)

View:
Quarterly Data
Annual Data
Note: All numbers in thousands

	Sep 30, 2008	Jun 30, 2008	Mar 31, 2008	Dec 31, 2007
Operating revenue
Total Revenue	368	389	199	905
Operating Revenue	368	389	199	905
Adjustments To Revenue	—	—	—	—
Cost Of Sales	-3	-20	-35	-1
Cost Of Sales With Depreciation	13	14	—	34
Gross Operating Profit	371	409	234	906
Operating Expenses
Research And Development Expenses	2,542	4,494	29,848	26,457
Selling General And Administrative Expenses	3,946	3,852	3,684	4,536
Advertising Expenses	—	—	—	—
Operating Income Before Depreciation	-6,117	-7,937	-33,298	-30,087
Operating Income	-6,133	-7,971	-33,333	-30,122
Depreciation	16	34	35	35
Depreciation Unreconciled	—	—	—	—
Amortization	—	—	—	—
Amortization Of Intangibles	—	—	—	—
Operating Income After Depreciation	-6,133	-7,971	-33,333	-30,122
Non Operating Expenses
Interest Expense	622	—	1,203	—
Pre Tax Income	-6,755	-7,697	-34,536	-29,225
Income Taxes	—	—	—	36
Minority Interest	—	—	—	—
Income Before Income Taxes	-6,755	-7,697	-34,536	-29,225
Net Income From Continuing Operations	-6,755	-7,697	-34,536	-29,261
Net Income From Discontinued Operations	-86	—	—	—
Net Income From Total Operations	-6,841	-7,697	-34,536	-29,261
Non Recurring Events
Extraordinary Income Losses	—	—	—	—
Income From Cummulated Effect Of Accounting Changes	—	—	—	—
Income From Tax Loss Carryforward	—	—	—	—
Other Gains And Losses	—	—	—	—
Total Net Income	-6,841	-7,697	-34,536	-29,261
Normalized Income	-6,755	-7,697	-34,536	-29,261
NetIncome Available For Common	-6,755	-7,697	-34,536	-29,261
Preferred Dividends	—	—	—	—
Excise Taxes	—	—	—	—

	Dec 31, 2007	Dec 31, 2006	Dec 31, 2005	Dec 31, 2004
Operating revenue
Total Revenue	1,049	534	574	809
Operating Revenue	1,049	534	574	809
Adjustments To Revenue	—	—	—	—
Cost Of Sales	11	306	629	680
Cost Of Sales With Depreciation	162	530	819	835
Gross Operating Profit	1,038	228	-55	129
Operating Expenses
Research And Development Expenses	78,463	62,643	24,776	29,018
Selling General And Administrative Expenses	17,005	17,518	4,191	4,668
Advertising Expenses	—	—	—	—
Operating Income Before Depreciation	-94,430	-79,933	-29,022	-33,557
Operating Income	-94,581	-80,157	-29,212	-33,712
Depreciation	151	224	190	155
Depreciation Unreconciled	—	—	—	—
Amortization	—	—	—	—
Amortization Of Intangibles	—	—	—	—
Operating Income After Depreciation	-94,581	-80,157	-29,212	-33,712
Non Operating Expenses
Interest Expense	—	—	—	27
Pre Tax Income	-90,026	-73,764	-26,895	-32,942
Income Taxes	36	—	—	1
Minority Interest	—	—	—	—
Income Before Income Taxes	-90,026	-73,764	-26,895	-32,942
Net Income From Continuing Operations	-90,062	-73,764	-26,895	-32,943
Net Income From Discontinued Operations	—	—	—	—
Net Income From Total Operations	-90,062	-73,764	-26,895	-32,943
Non Recurring Events
Extraordinary Income Losses	—	—	—	—
Income From Cummulated Effect Of Accounting Changes	—	—	—	—
Income From Tax Loss Carryforward	—	—	—	—
Other Gains And Losses	—	—	—	—
Total Net Income	-90,062	-73,764	-26,895	-32,943
Normalized Income	-90,062	-73,764	-26,895	-32,943
NetIncome Available For Common	-90,062	-73,764	-26,895	-32,943
Preferred Dividends	—	—	—	—
Excise Taxes	—	—	—	—